These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9274650)

  • 21. Childhood epidermolysis bullosa acquisita with underlying coeliac disease.
    Kasperkiewicz M; Orosz I; Abeck D; Koletzko S; Ruzicka T; Sárdy M
    Acta Derm Venereol; 2015 Nov; 95(8):1013-4. PubMed ID: 25824338
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful treatment of refractory epidermolysis bullosa acquisita with intravenous immunoglobulin and dapsone.
    McLawhorn JM; Johnson AW; Kim KH; Addis K
    Cutis; 2019 Aug; 104(2):E20-E21. PubMed ID: 31603972
    [No Abstract]   [Full Text] [Related]  

  • 23. [Aminosalicylates in the treatment of idiopathic inflammatory bowel disease].
    Lukás K
    Vnitr Lek; 1996 Feb; 42(2):117-9. PubMed ID: 8686186
    [No Abstract]   [Full Text] [Related]  

  • 24. Childhood epidermolysis bullosa acquisita. Report of three cases and review of literature.
    Arpey CJ; Elewski BE; Moritz DK; Gammon WR
    J Am Acad Dermatol; 1991 May; 24(5 Pt 1):706-14. PubMed ID: 1869641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of recalcitrant epidermolysis bullosa acquisita responsive to rituximab therapy.
    McKinley SK; Huang JT; Tan J; Kroshinsky D; Gellis S
    Pediatr Dermatol; 2014; 31(2):241-4. PubMed ID: 23106762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Will the real 5-aminosalicylic acid please stand up?
    Regueiro MD
    Inflamm Bowel Dis; 1999 May; 5(2):147-8. PubMed ID: 10338387
    [No Abstract]   [Full Text] [Related]  

  • 27. Case of concurrent epidermolysis bullosa acquisita and anti-p200 pemphigoid--how to treat it?
    Pastar Z; Rados J; Lipozencic J; Dobric I; Marinovic B; Ishii N; Hashimoto T
    Int J Dermatol; 2007 Mar; 46(3):295-8. PubMed ID: 17343589
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab.
    Sadler E; Schafleitner B; Lanschuetzer C; Laimer M; Pohla-Gubo G; Hametner R; Hintner H; Bauer JW
    Br J Dermatol; 2007 Aug; 157(2):417-9. PubMed ID: 17596155
    [No Abstract]   [Full Text] [Related]  

  • 29. Clearing of epidermolysis bullosa acquisita with cyclosporine.
    Mallett RB; Holden CA
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):1034-5. PubMed ID: 1869675
    [No Abstract]   [Full Text] [Related]  

  • 30. [5-ASA versus sulfasalazine].
    Varela E
    Acta Gastroenterol Latinoam; 1994; 25(5):317-9. PubMed ID: 7785405
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral colchicine monotherapy for epidermolysis bullosa acquisita: Mechanism of action and efficacy.
    Adachi A; Komine M; Suzuki M; Murata S; Hirano T; Ishii N; Hashimoto T; Ohtsuki M
    J Dermatol; 2016 Nov; 43(11):1389-1391. PubMed ID: 27153772
    [No Abstract]   [Full Text] [Related]  

  • 32. A case of epidermolysis bullosa acquisita associated with laryngeal stenosis.
    Kiniwa Y; Ashida A; Ohashi A; Kitoh R; Fukuda S; Hashimoto T; Okuyama R
    Acta Derm Venereol; 2012 Jan; 92(1):93-4. PubMed ID: 22215014
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term efficacy of extracorporeal photochemotherapy in a patient with refractory epidermolysis bullosa acquisita.
    Baroudjian B; Le Roux-Villet C; Bréchignac S; Alexandre M; Caux F; Prost-Squarcioni C; Laroche L
    Eur J Dermatol; 2012; 22(6):795-7. PubMed ID: 23228865
    [No Abstract]   [Full Text] [Related]  

  • 34. Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis.
    Hanauer SB
    Gut; 1999 Apr; 44(4):455. PubMed ID: 10075949
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH; Munck LK
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of rituximab in treatment of epidermolysis bullosa acquisita: Three new cases and a review of the literature.
    Bevans SL; Sami N
    Dermatol Ther; 2018 Nov; 31(6):e12726. PubMed ID: 30284354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermolysis bullosa acquisita treated with basiliximab, an interleukin-2 receptor antibody.
    Haufs MG; Haneke E
    Acta Derm Venereol; 2001; 81(1):72. PubMed ID: 11411931
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of Diverticular Disease With Aminosalicylates: The Evidence.
    Barbara G; Cremon C; Barbaro MR; Bellacosa L; Stanghellini V
    J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S60-3. PubMed ID: 27622369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Epidermolysis bullosa acquisita with dupilumab.
    Diehl R; Kiritsi D; Schauer F
    J Dtsch Dermatol Ges; 2024 Oct; 22(10):1417-1419. PubMed ID: 39094124
    [No Abstract]   [Full Text] [Related]  

  • 40. Epidermolysis bullosa acquisita.
    Cobos G; Mu E; Cohen J; Beasley J; Brinster N; Femia A
    Dermatol Online J; 2017 Dec; 23(12):. PubMed ID: 29447655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.